SCHEMBL8212102

SCHEMBL8212102

NC(=O)C(CO)NP

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8213075 1.00
SCHEMBL13577533 1.00
SCHEMBL12514893 0.79
SCHEMBL13640858 0.79
SCHEMBL13577575 0.79
SCHEMBL8214358 0.77
SCHEMBL14050301 0.77 TGFBR1 (0.50)
SCHEMBL77750 0.76
SCHEMBL5132096 0.76
SCHEMBL77751 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020023386-A1 GIP/GLP1 CO-AGONIST COMPOUNDS ELI LILLY AND COMPANY (US) 2020-01-30 WO disclosed
US-9012398-B2 Acylated exendin-4 compounds NOVO NORDISK A/S (DK) 2015-04-21 US disclosed
EP-2057189-B1 ACYLATED EXENDIN-4 COMPOUNDS NOVO NORDISK AS (DK) 2013-03-06 EP disclosed
US-20120283170-A1 Acylated Exendin-4 Compounds NOVO NORDISK A/S (DK) 2012-11-08 US disclosed
EP-2330126-A1 Protracted exendin-4 compounds NOVO NORDISK A/S (DK) 2011-06-08 EP disclosed
US-20090318353-A1 Acylated Exendin-4 Compounds NOVO NORDISK A/S (DK) 2009-12-24 US disclosed
WO-2008023050-A1 ACYLATED EXENDIN-4 COMPOUNDS NOVO NORDISK A/S (DK) 2008-02-28 WO disclosed
WO-2006097536-A2 DIMERIC PEPTIDE AGONISTS OF THE GLP-1 RECEPTOR NOVO NORDISK A/S (DK) 2006-09-21 WO disclosed
WO-2006037811-A2 PROTRACTED EXENDIN-4 COMPOUNDS NOVO NORDISK A/S (DK) 2006-04-13 WO disclosed